IMMU

IMMU Articles

24/7 Wall St. has taken a look at a few of the major ASCO winners so far. Color and background information has also been added on each, as well as how shares have been moving and the consensus price...
Investors and traders alike need to keep in mind that low-priced and small-cap stocks almost always come with more implied risks than well-established blue chips.
Immunomedics may be poised to make big moves going forward in 2015, according to Wells Fargo.
After Immunomedics announced that it had appointed a new chief medical officer, Wells Fargo issued an analyst call implying upside of over 50%.
Wednesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include ADP, Cigna, First Solar, Garmin, LINN Energy and Synchrony.
These were the top analyst stocks to buy under $10 seen in research calls issued this past week.
The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers. They all have 50% or higher upside to the firm's price target.
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the difference...
ThinkstockIt is not unusual to see biotech and biohealth companies raise cash after good news. After all, these companies either need to raise lots of cash from the market to fund their research and...
There are many companies that deserved to be on this weekend’s slate of unusual suspects that have key current developments to watch in this coming week.  Some are unusual trading activity, some...
These are this Thursday morning’s top day trader and active trader alerts with links through to each story with more detailed price and volume analysis over at VSInvestor.com: American...
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks.  The American Association for Cancer Research Meeting will actually have a 100th annual...